Reverse osmosis membrane and method of producing the same
US-2024307831-A1 · Sep 19, 2024 · US
US12397266B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12397266-B2 |
| Application number | US-202017642625-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 9, 2020 |
| Priority date | Sep 13, 2019 |
| Publication date | Aug 26, 2025 |
| Grant date | Aug 26, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to the field of biomimetic membranes with artificial water channels, notably the use thereof in the context of the production and management of drinking water. The present invention relates to a biomimetic membrane with artificial water channels, the method of synthesis thereof, as well as the use thereof for desalination of brackish water and seawater, production of ultra-pure water or filtration of contaminants.
Opening claim text (preview).
The invention claimed is: 1. A composite biomimetic membrane, comprising: an ultrafiltration supporting membrane, at least one compound of Formula I: in which, R represents a linear or branched C4 to C8 alkyl group, X represents S or O, and a crosslinked polyamide film, wherein the at least one compound of Formula I is in a form of supramolecular aggregates of an imidazole-quartet, distributed homogeneously in a rigid matrix formed by the crosslinked polyamide film, wherein the supramolecular aggregates are in a form of crystalline aggregates having an average diameter ranging from 20 nm to 40 nm and are made up of self-organized lamellar phases containing artificial water channels of the imidazole-quartet, and wherein homogeneous ridge-and-valley protrusions are arranged over the entire surface of the composite biomimetic membrane. 2. The composite biomimetic membrane according to claim 1 , wherein the ultrafiltration supporting membrane has a molecular weight cutoff within a range from 10 Kilodaltons (kD) to 250 Kilodaltons (kD). 3. The composite biomimetic membrane according to claim 1 , wherein the compound of formula I is selected from the compounds of formula II: in which R 1 represents butyl or hexyl. 4. The composite biomimetic membrane according to claim 1 , wherein the crosslinked polyamide film has a thickness from 0.05 μm to 0.4 μm. 5. The composite biomimetic membrane according to claim 1 , wherein the crosslinked polyamide film is a crosslinked polyamide of a di- or triamine monomer and of a di- or tri-acyl chloride monomer, at least one of the monomers being trivalent. 6. The composite biomimetic membrane according to claim 1 , wherein R is selected from butyl, pentyl, hexyl, heptyl or octyl functional group. 7. The composite biomimetic membrane according to claim 1 , wherein the crosslinked polyamide film has a thickness from 0.05 μm to 0.4 μm. 8. A method of manufacturing the composite biomimetic membrane recited in claim 1 , comprising the steps: a) impregnating a surface of an ultrafiltration supporting membrane with a colloidal suspension in a form of supramolecular aggregates, thereby forming an impregnated membrane, wherein the colloidal suspension comprises at least one compound of Formula I: in which, R represents a C4 to C8 alkyl functional group selected from butyl, pentyl, hexyl, heptyl or octyl functional group, X represents S or O; and b) forming a crosslinked polyamide film by conducting an interfacial polymerization on a surface of the impregnated membrane obtained in step a), and subsequently producing the composite biomimetic membrane, wherein the at least one compound of Formula I is in a form of supramolecular aggregates of an imidazole-quartet, distributed homogeneously in a rigid matrix formed by the crosslinked polyamide film, wherein the supramolecular aggregates are crystalline aggregates having an average diameter from 20 nm to 40 nm and are comprised of self-organized lamellar phases containing artificial water channels of the imidazole-quartet, and wherein homogeneous ridge-and-valley protrusions are arranged over the entire surface of the composite biomimetic membrane. 9. The method according to claim 8 , in which the colloidal suspension comprises an organic solvent and/or water. 10. The method according to claim 8 , in which the interfacial polymerization comprises the substeps: i) impregnating the surface of the impregnated membrane obtained in step a) with a solution comprising a di- or triamine monomer; ii) impregnating the surface of the impregnated membrane obtained in step i) with a solution comprising a di or tri acyl chloride monomer; and iii) polymerizing the impregnated membrane obtained in step ii) by immersion in water, at a temperature greater than or equal to 50° C. 11. The method according to claim 8 , further comprising a step of rinsing the composite biomimetic membrane. 12. A method for desalinating drinking water, brackish water, or seawater by using the composite biomimetic membrane recited in claim 1 , comprising the step of contacting drinking water, brackish water, or seawater with the composite biomimetic membrane.
Polyamides derived from polyamines and polycarboxylic acids (C08L77/10 takes precedence) · CPC title
Polyamides, e.g. polyester-amides · CPC title
by interfacial polymerisation · CPC title
Seawater, e.g. for desalination · CPC title
Characteristic thickness · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.